Geoffrey M. Parker, Director at Better Therapeutics, Inc. (BTTX), bought 15,000 shares at $2.15 ($32K) on 2022-03-29, disclosed to the SEC on 2022-03-31.
Open-market purchase of $32k BTTX by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| ALLO | SELL | 2025-10-23 | $46K | — | Filing → |
| PRGO | BUY | 2025-08-20 | $201K | — | Filing → |
| PRGO | BUY | 2025-05-14 | $95K | — | Filing → |